NCT02149602View on ClinicalTrials.gov

A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

November 30, 2011

Study Completion Date

January 31, 2014

Conditions
Oropharyngeal Squamous Cell CancerHypopharyngeal Squamous Cell Cancer
Interventions
RADIATION

Intensity modulated radiotherapy

Bilateral superficial lobe parotid sparing intensity modulated radiotherapy

Trial Locations (1)

SW3 6JJ

Head and Neck Unit, Royal Marsden Hospital, London

All Listed Sponsors
lead

Royal Marsden NHS Foundation Trust

OTHER

NCT02149602 - A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck | Biotech Hunter | Biotech Hunter